SPOTLIGHT -
Psoriasis Severity Could Signal Increased Cardiovascular Risk
Pulmonary Embolism 101 with Parth Rali, MD
Abelacimab Demonstrates "Overwhelming" Efficacy vs Rivaroxaban in Phase 2b Trial
Don't Miss a Beat: ESC Heart Failure Association Preview
Discussing Advances in Structural Heart Disease, with Elliot Elias, MD, MPH
Empagliflozin Provides Consistent Benefit in HFrEF, Regardless of Diuretic Use